晚期NSCLC的瘤性改变:一个分子超级高速公路
Alex Friedlaender1,2, Maurice Perol3, Giuseppe Luigi Banna4,5
1Clinique Générale Beaulieu, Geneva, Switzerland.
Biomarker research
|February 12, 2024
概括
肺癌治疗在精准医学方面取得了进展. 识别非小细胞肺癌 (NSCLC) 中的分子瘤原因驱动因素指导了针对性治疗,以改善患者的治疗结果.
科学领域:
- 瘤学和分子生物学
- 遗传学和基因组学 在
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺癌是全球癌症死亡的主要原因,非小细胞肺癌 (NSCLC) 是最常见的类型.
- 近几十年来,基于分子瘤原体子集的NSCLC分类取得了重大进展,影响了预后和治疗.
- 如今,可向的分子变异,如EGFR,已在相当大比例的肺腺癌患者中被发现,特别是在亚洲人群中.
研究的目的:
- 审查目前在先进的NSCLC中致癌驱动因素变化的现状.
- 讨论基于分子分析的NSCLC的诊断方法和管理策略.
- 探索肺癌精准医学领域的未来前景和挑战.
主要方法:
- 关于NSCLC分子变化的当前文献的综述.
- 讨论诊断技术,包括下一代测序 (NGS).
- 对向疗法和抗药机制的分析.
主要成果:
- 大约60-80%的肺腺癌患者具有可向的分子变化.
- 关键的可用药物标包括EGFR,ALK,BRAF,ROS1,KRAS,HER2,MET,NTRK,RET和NRG1,PI3K和FGFR也在调查中.
- 致癌驱动因素在非吸烟者,东亚人和年轻患者中更为普遍.
结论:
- 精准医学,由像NGS这样的分子诊断驱动,对于个性化NSCLC治疗至关重要.
- 鉴定瘤原体驱动因素可以选择有针对性的治疗和治疗耐药性.
- 持续的研究对于克服挑战和进一步完善肺癌治疗策略至关重要.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


